Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 397864-44-7
- Molecular formula
- C27H29F3O6S
- Molecular weight
- 538.6 g/mol
- Drug class
- Synthetic glucocorticoidintranasal/inhaled corticosteroid anti-inflammatory agent
- Mechanism of action
- Activates intracellular glucocorticoid receptors and suppresses inflammatory cytokines and mediator release in airway and nasal tissues. The clinical mechanism depends on the route and whether fluticasone furoate is used alone or in a fixed combination.
- Indications / reported uses
- Treatment of allergic rhinitis symptoms with intranasal fluticasone furoate products
- Maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) only in authorised fixed combinations with a long-acting bronchodilator; fluticasone monotherapy and combination-product indications are not interchangeable
Identification source: PubChem record (CID 9854489). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.